Answers are grounded in this paper and cite their sources.
Intracranial hemorrhage can occur as a rare, delayed complication 4 days after fibrinolytic therapy for STEMI, highlighting the need for vigilance for neurological symptoms beyond the typical 24-hour window.
Intracranial haemorrhage is a known complication after fibrinolytic therapy and occurs usually in the first 24 h. We report a 35-year-old woman who presented with severe central chest pain and she was diagnosed as anterior ST elevation myocardial infarction. She was given fibrinolytic therapy with Tenecteplase. She responded well to the treatment with a decrease in the intensity of chest pain and resolution of the ST segment elevation. She was taken for coronary angiogram the next day, which revealed an occlusion of the left anterior descending (LAD) artery, and stenting of LAD was carried out. Four days later, she developed severe headache, confusion, slurring of speech and right haemiparesis. CT brain revealed intracerebral haemorrhage and she was referred to an neurosurgeon who advised for conservative management. Her condition gradually improved with physiotherapy and was discharged home with no marked functional impairment.
No takes yet. Share an insight, caveat, or question.
Ali et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: